Detection of monoclonal IGH rearrangements in circulating cells from healthy first-degree relatives of patients with multiple myeloma

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Medical Oncology

• Publication date

  2014-03-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s12032-014-0900-0PMID 24577939
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Circulating clonotypic B cells in multiple myeloma and monoclonal gammopathy of undetermined significance

  2014cited by this paper
• Detailed characterization of multiple myeloma circulating tumor cells shows unique phenotypic, cytogenetic, functional, and circadian distribution profile.

  2013cited by this paper
• The use of CD138 positively selected marrow samples increases the applicability of minimal residual disease assessment by PCR in patients with multiple myeloma

  2012cited by this paper
• Competition between clonal plasma cells and normal cells for potentially overlapping bone marrow niches is associated with a progressively altered cellular distribution in MGUS vs myeloma

  2011cited by this paper
• Plasma cell myeloma.

  2009cited by this paper
• Increased risk of monoclonal gammopathy in first-degree relatives of patients with multiple myeloma or monoclonal gammopathy of undetermined significance.

  2008cited by this paper
• Report of the European Myeloma Network on multiparametric flow cytometry in multiple myeloma and related disorders

  2008cited by this paper
• Molecular characterization of heavy chain immunoglobulin gene rearrangements in Waldenström's macroglobulinemia and IgM monoclonal gammopathy of undetermined significance.

  2007cited by this paper
• A practical strategy for the routine use of BIOMED‐2 PCR assays for detection of B‐ and T‐cell clonality in diagnostic haematopathology

  2007cited by this paper
• Significantly improved PCR-based clonality testing in B-cell malignancies by use of multiple immunoglobulin gene targets. Report of the BIOMED-2 Concerted Action BHM4-CT98-3936

  2007cited by this paper
• Minimal disease detection and confirmation in hematologic malignancies: combining cell sorting with clonality profiling.

  2006cited by this paper
• Prevalence of monoclonal gammopathy of undetermined significance.

  2006cited by this paper
• The phenotype of normal, reactive and malignant plasma cells. Identification of "many and multiple myelomas" and of new targets for myeloma therapy.

  2006cited by this paper
• Incidence of monoclonal B-cell disease in siblings of patients with multiple myeloma.

  2006cited by this paper
• Validation of immunoglobulin gene rearrangement detection by PCR using commercially available BIOMED-2 primers

  2006cited by this paper
• Molecular characteristics and gene segment usage in IGH gene rearrangements in multiple myeloma.

  2005cited by this paper
• Familiality of benign and malignant paraproteinemias. A population-based cancer-registry study of multiple myeloma families.

  2005cited by this paper
• Phenotypic heterogeneity in multiple myeloma families.

  2005cited by this paper
• Incomplete DJH rearrangements of the IgH gene are frequent in multiple myeloma patients: immunobiological characteristics and clinical implications

  2003cited by this paper
• Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group

  2003cited by this paper
• Incomplete DJH rearrangements as a novel tumor target for minimal residual disease quantitation in multiple myeloma using real-time PCR

  2003cited by this paper
• Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: Report of the BIOMED-2 Concerted Action BMH4-CT98-3936

  2003cited by this paper
• A long-term study of prognosis in monoclonal gammopathy of undetermined significance.

  2002cited by this paper
• Inherited predisposition to CLL is detectable as subclinical monoclonal B-lymphocyte expansion.

  2002cited by this paper
• Immunomagnetic enrichment of CD138 positive cells from weakly infiltrated myeloma patients samples enables the determination of the tumor clone specific IgH rearrangement

  2001cited by this paper
• Comparison of Capillary Electrophoresis and Polyacrylamide Gel Electrophoresis for the Evaluation of T and B Cell Clonality by Polymerase Chain Reaction

  2000cited by this paper
• Monoclonal gammopathies of undetermined significance.

  1999cited by this paper
• Heteroduplex PCR analysis of rearranged immunoglobulin genes for clonality assessment in multiple myeloma.

  1999cited by this paper
• Distribution of myeloma plasma cells in peripheral blood and bone marrow correlates with CD56 expression

  1999cited by this paper
• Normal and clonal B lineage cells can be distinguished by their differential expression of B cell antigens and adhesion molecules in peripheral blood from multiple myeloma (MM) patients—diagnostic and clinical implications

  1998cited by this paper
• Circulating plasma cells in multiple myeloma: characterization and correlation with disease stage

  1997cited by this paper
• Clonal circulating cells are common in plasma cell proliferative disorders: a comparison of monoclonal gammopathy of undetermined significance, smoldering multiple myeloma, and active myeloma.

  1996cited by this paper
• The blood B-cells and bone marrow plasma cells in patients with multiple myeloma share identical IgH rearrangements.

  1995cited by this paper
• Detection and quantitation of malignant cells in the peripheral blood of multiple myeloma patients.

  1992cited by this paper
• Analysis of B-lymphoid malignancies using allele-specific polymerase chain reaction: a technique for sequential quantitation of residual disease.

  1991cited by this paper
• Circulating monoclonal B lymphocytes in multiple myeloma

  1989cited by this paper

• Monitoring immunoglobulin heavy chain and T-cell receptor gene rearrangement in cfDNA as minimal residual disease detection for patients with acute myeloid leukemia

  2018cites this paper
• Detection of monoclonal B cells in general population from two different regions of Mexico

  2017cites this paper